drug screening

New York, United States – August 4, 2026 Pathos AI has announced a landmark global licensing agreement with Jiangsu...

Chicago, Illinois – August 3, 2026 Meitheal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...

Cambridge, Massachusetts, August 3, 2026 Akebia Therapeutics, Inc. announced the initiation of an open-label Phase 2 basket trial of...

New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...

NEW YORK, July 21, 2026 Intelligent Bio Solutions Inc. announced the successful completion of precision testing, an important milestone...

NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...

NEW YORK, April 2, 2026 Intelligent Bio Solutions Inc. has achieved a critical milestone in its regulatory journey by...